Sept. 6, 2012
/PRNewswire/ -- Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential wrongdoing at AmerisourceBergen Corporation ("ABC" or the "Company") (NYSE: ABC). The investigation focuses on whether certain officers and directors of ABC violated their fiduciary duties to the Company by failing to ensure that ABC had adequate internal controls to prevent the diversion of controlled substances to illegitimate channels.
Request more information now by clicking here:
August 9, 2012
, ABC, a prescription drug wholesaler, disclosed that it had received subpoenas from the U.S. Attorney's Office in
and the Drug Enforcement Agency ("DEA") involving the Company's processes for handling controlled substances. The subpoenas are connected to a grand jury proceeding seeking documents about ABC's program for controlling and monitoring the diversion of controlled substances into illegitimate channels. Furthermore, in
Attorney General filed a lawsuit against the Company alleging that ABC failed to provide effective controls and procedures to guard against the diversion of controlled substances for illegal purposes in West Virginia.
Faruqi & Faruqi, LLP is a national law firm representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The firm is focused on providing exemplary legal services in complex litigation. Founded in 1995, the firm maintains its principal office in
New York City
, with offices in
and Pennsylvania. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.
If you are a current ABC shareholder, and you would like to discuss your legal rights, visit
. You can also contact us by calling
Beth A. Keller
toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to